News
Nurses are expected to escalate their protest for better pay over the coming weeks as union members take industrial action for the first time in two decades. Queensland Nurses and Midwives Union ...
ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA n
New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal antibody, reinforce its potential as a disease-modifying treatment for IgA nephropathy (IgAN) ...
Smoothie bowls have become a perfect breakfast canvas for people who enjoy extra morning time during their work-from-home routines.
An alleged risk of patients breathing in or swallowing small particles of foam from degrading sleep aids has prompted the federal government to take legal action. Multinational health technology ...
The expansion cohort for pancreatic ductal adenocarcinoma (PDAC) in the ongoing Phase 1 trial has completed enrolment. Notably, 82% of patients had tumours expressing the antigen at levels considered ...
You will work closely with the Operations Manager of Planned Surgery, the Deputy Elective Surgery Manager, and the rest of the Planned Surgery team to manage and coordinate the care of patients on the ...
Sexual violence is becoming more prevalent in conflicts and experts are calling on Australia to hold state and non-state perpetrators accountable. For the first time, Australia is hosting an ...
Australians with O-type blood are being asked to roll up their sleeves as storages hit their lowest point since 2023. An extra 9500 donations of O positive and O negative blood donors are needed in ...
Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard therapies cut the risk of disease progression or death by half, a finding ...
Structured exercise programs could reduce colon cancer deaths by more than a third, as researchers find a game-changer way to to treat the disease. A study by the University of Sydney over 17 years ...
French scientist Etienne-Emile Baulieu, best known as the inventor of the abortion pill RU 486, has died aged 98 at his home in Paris. Both a doctor and a researcher, Baulieu was known around the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results